Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

1.

Clonazepam treatment of obsessions and compulsions.

Hewlett WA, Vinogradov S, Agras WS.

J Clin Psychiatry. 1990 Apr;51(4):158-61.

PMID:
2182614
[PubMed - indexed for MEDLINE]
2.

Clomipramine, clonazepam, and clonidine treatment of obsessive-compulsive disorder.

Hewlett WA, Vinogradov S, Agras WS.

J Clin Psychopharmacol. 1992 Dec;12(6):420-30.

PMID:
1474179
[PubMed - indexed for MEDLINE]
3.

Serotonergic medications for sexual obsessions, sexual addictions, and paraphilias.

Stein DJ, Hollander E, Anthony DT, Schneier FR, Fallon BA, Liebowitz MR, Klein DF.

J Clin Psychiatry. 1992 Aug;53(8):267-71.

PMID:
1386848
[PubMed - indexed for MEDLINE]
4.

Clonazepam in the treatment of obsessive compulsive disorder associated with panic disorder in one patient.

Bodkin JA, White K.

J Clin Psychiatry. 1989 Jul;50(7):265-6.

PMID:
2738031
[PubMed - indexed for MEDLINE]
5.

Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study.

Flament MF, Rapoport JL, Berg CJ, Sceery W, Kilts C, Mellström B, Linnoila M.

Arch Gen Psychiatry. 1985 Oct;42(10):977-83.

PMID:
3899048
[PubMed - indexed for MEDLINE]
6.

Lithium and tryptophan augmentation in clomipramine-resistant obsessive-compulsive disorder.

Rasmussen SA.

Am J Psychiatry. 1984 Oct;141(10):1283-5.

PMID:
6435460
[PubMed - indexed for MEDLINE]
7.

Fluoxetine treatment of obsessive-compulsive disorder.

Turner SM, Jacob RG, Beidel DC, Himmelhoch J.

J Clin Psychopharmacol. 1985 Aug;5(4):207-12.

PMID:
3894437
[PubMed - indexed for MEDLINE]
8.

Absence of placebo response in obsessive-compulsive disorder.

Mavissakalian MR, Jones B, Olson S.

J Nerv Ment Dis. 1990 Apr;178(4):268-70.

PMID:
2319236
[PubMed - indexed for MEDLINE]
9.

Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment.

Zohar J, Insel TR, Zohar-Kadouch RC, Hill JL, Murphy DL.

Arch Gen Psychiatry. 1988 Feb;45(2):167-72.

PMID:
3276283
[PubMed - indexed for MEDLINE]
10.

Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline.

Insel TR, Murphy DL, Cohen RM, Alterman I, Kilts C, Linnoila M.

Arch Gen Psychiatry. 1983 Jun;40(6):605-12.

PMID:
6342562
[PubMed - indexed for MEDLINE]
11.

Clonazepam as an augmenting agent in the treatment of childhood-onset obsessive-compulsive disorder.

Leonard HL, Topol D, Bukstein O, Hindmarsh D, Allen AJ, Swedo SE.

J Am Acad Child Adolesc Psychiatry. 1994 Jul-Aug;33(6):792-4.

PMID:
8083135
[PubMed - indexed for MEDLINE]
12.

Lack of efficacy of low doses of quetiapine addition in refractory obsessive-compulsive disorder.

Sevincok L, Topuz A.

J Clin Psychopharmacol. 2003 Oct;23(5):448-50.

PMID:
14520120
[PubMed - indexed for MEDLINE]
13.

Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients.

Zohar J, Kaplan Z, Benjamin J.

J Clin Psychiatry. 1993 Oct;54(10):385-8.

PMID:
7903293
[PubMed - indexed for MEDLINE]
14.

Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results.

Pigott TA, Pato MT, Bernstein SE, Grover GN, Hill JL, Tolliver TJ, Murphy DL.

Arch Gen Psychiatry. 1990 Oct;47(10):926-32.

PMID:
2222131
[PubMed - indexed for MEDLINE]
15.

Delayed obsessive-compulsive disorder symptom exacerbation after a single dose of a serotonin antagonist in fluoxetine-treated but not untreated patients.

Greenberg BD, Benjamin J, Martin JD, Keuler D, Huang SJ, Altemus M, Murphy DL.

Psychopharmacology (Berl). 1998 Dec;140(4):434-44.

PMID:
9888619
[PubMed - indexed for MEDLINE]
16.

Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy.

Alonso P, Menchon JM, Pifarre J, Mataix-Cols D, Torres L, Salgado P, Vallejo J.

J Clin Psychiatry. 2001 Jul;62(7):535-40.

PMID:
11488364
[PubMed - indexed for MEDLINE]
17.

Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients.

Greist JH, Jefferson JW, Rosenfeld R, Gutzmann LD, March JS, Barklage NE.

J Clin Psychiatry. 1990 Jul;51(7):292-7.

PMID:
2195006
[PubMed - indexed for MEDLINE]
18.

Obsessive-compulsive symptoms in schizophrenia: a comparison of olanzapine and placebo.

Baker RW, Ames D, Umbricht DS, Chengappa KN, Schooler NR.

Psychopharmacol Bull. 1996;32(1):89-93.

PMID:
8927681
[PubMed - indexed for MEDLINE]
19.

Long-term follow-up of 85 patients with obsessive-compulsive disorder.

Orloff LM, Battle MA, Baer L, Ivanjack L, Pettit AR, Buttolph ML, Jenike MA.

Am J Psychiatry. 1994 Mar;151(3):441-2.

PMID:
8109659
[PubMed - indexed for MEDLINE]
20.

Fluvoxamine treatment of obsessive-compulsive disorder.

Perse TL, Greist JH, Jefferson JW, Rosenfeld R, Dar R.

Am J Psychiatry. 1987 Dec;144(12):1543-8.

PMID:
3120604
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk